ReCor Medical
Palo Alto
About ReCor Medical
ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a more efficient renal denervation procedure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $25.0M
- Funding stage: M&A
- Last round: Debt Financing (Jun 2016)
- Website: recormedical.com
- Phone: +31207940000
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/recor-medical-74518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.